| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Sep 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.02B | 5.54B | 7.04B | 7.49B | 9.28B | 11.12B |
| Gross Profit | 2.15B | 2.17B | 2.76B | 2.98B | 3.34B | 3.55B |
| EBITDA | 3.71B | 2.87B | 2.24B | 2.39B | 1.81B | 1.07B |
| Net Income | 3.50B | 2.17B | 1.61B | 1.76B | 1.30B | 256.03M |
Balance Sheet | ||||||
| Total Assets | 53.51B | 56.83B | 65.25B | 76.34B | 95.16B | 115.32B |
| Cash, Cash Equivalents and Short-Term Investments | 9.88B | 12.97B | 15.05B | 5.90B | 11.76B | 8.59B |
| Total Debt | 22.77B | 28.61B | 39.26B | 51.22B | 71.21B | 91.74B |
| Total Liabilities | 23.73B | 29.28B | 39.86B | 51.92B | 72.52B | 94.13B |
| Stockholders Equity | 29.78B | 27.54B | 25.39B | 24.43B | 22.64B | 21.20B |
Cash Flow | ||||||
| Free Cash Flow | 11.66B | 11.36B | 25.62B | 18.87B | 27.20B | 13.11B |
| Operating Cash Flow | 11.66B | 11.39B | 25.63B | 18.87B | 27.21B | 13.11B |
| Investing Cash Flow | -10.83B | 7.76B | -6.89B | 2.59B | -1.54B | -1.62B |
| Financing Cash Flow | -7.22B | -13.83B | -16.69B | -24.59B | -27.19B | -8.83B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | ₹33.34B | 23.71 | ― | 0.92% | 9.70% | 28.71% | |
65 Neutral | ₹45.40B | 12.44 | ― | 0.29% | 13.42% | -7.64% | |
56 Neutral | ₹20.06B | 11.02 | ― | ― | -15.30% | 92.21% | |
49 Neutral | ₹16.75B | 6.63 | ― | ― | 39.48% | 61.62% | |
44 Neutral | ₹13.61B | 48.24 | ― | 2.64% | -5.76% | -26.44% | |
44 Neutral | ₹20.11B | -5.67 | ― | ― | -55.39% | -139.16% |